tiprankstipranks
Trending News
More News >
Pennant Group Inc (PNTG)
NASDAQ:PNTG
US Market

Pennant Group (PNTG) Earnings Dates, Call Summary & Reports

Compare
97 Followers

Earnings Data

Report Date
May 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.31
Last Year’s EPS
0.27
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasizes significant top-line and bottom-line growth in 2025, strong organic same-store improvements, high clinical quality, successful M&A activity and conservative but growth-oriented FY2026 guidance. Management is transparent about near-term integration risks, transition-service costs, and reimbursement headwinds related to the large October acquisitions that will cause some operational noise in early 2026. Given the scale of positive financial results, clinical outperformance, clear integration plan and a healthy balance sheet that leaves room for further investments, the positives materially outweigh the outlined short-term challenges.
Company Guidance
Pennant's 2026 guidance is annual (not quarterly) and assumes revenue of $1.13–$1.17 billion (midpoint up ~22.4%), adjusted EBITDA of $88.5–$94.1 million (midpoint up ~26%), adjusted EBITDA prior to NCI of $94.2–$100.0 million (midpoint up ~26.7%) and adjusted EPS of $1.26–$1.36 (midpoint $1.31), based on roughly 37 million diluted shares and a 26% effective tax rate with an expected quarter‑by‑quarter ramp (Q‑over‑Q EPS growth) as more than 50 recently acquired locations transition; the modeling embeds about 7% same‑store home health/hospice revenue growth, senior‑living assumptions of ~100 bps occupancy improvement and ~6% RevPOR growth, G&A around 6.4–6.5% of revenue, operating cash flow of $45–$55 million and CapEx of ~ $15 million, and excludes unannounced acquisitions, start‑ups, share‑based comp, acquisition‑related costs, certain TSA costs and other one‑time items.
Strong Full-Year Financial Performance
FY2025 consolidated revenue of $947.7M, up $252.5M or 36.3% year-over-year; adjusted EBITDA of $72.5M, up $19.2M or 36%; adjusted EBITDA prior to NCI $76.7M, up $21.6M or 39.2%; full-year adjusted EPS $1.18, exceeding the midpoint of updated guidance ($1.16).
Robust Fourth Quarter Home Health & Hospice Growth
Q4 Home Health & Hospice revenue of $233.3M, up $91.3M or 64.3% YoY; Q4 adjusted EBITDA $33.7M, up $12.4M or 58.2%; Q4 admissions surged 81.3% and Medicare admissions grew 87.5% YoY; same-store Medicare admissions +8.2% and Medicare revenue per episode +3.7% YoY.
High Clinical Quality Metrics
Average CMS home health star rating rose to 4.2 (national average 3.0); hospice CMS quality composite score 97.5%; Columbia River example: CMS star 4.5, potentially preventable hospitalizations 6.2% vs national 10.8%.
Accelerating Hospice Performance
Hospice average daily census of 5,060 in Q4, up 46.9% YoY; same-store hospice ADC +8.4%, admissions +6.6%, and hospice Medicare revenue per day +5.9% YoY.
Senior Living Momentum
FY2025 Senior Living revenue $215M, up $39.2M or 22.3% YoY; Q4 revenue $56.1M, up 19.6% YoY; Q4 Senior Living adjusted EBITDA $6.1M, up $1.9M or 46%; all-store occupancy up 200 bps to 80.6%, same-store occupancy up 250 bps to 82.1%, RevPOR +5.6% YoY.
Strategic M&A Execution and Scale Expansion
Completed Signature Healthcare at Home integration (Jan 1, 2025) and closed largest acquisition in history—over 50 locations from UnitedHealth and Amedisys (Oct 2025); opportunistic senior living operations and real estate acquisitions (two senior living deals closed in Q4).
Conservative, Growth-Oriented 2026 Guidance
2026 guidance: revenue $1.13B–$1.17B (midpoint +22.4%), adjusted EBITDA $88.5M–$94.1M (midpoint +26%), adjusted EBITDA prior to NCI $94.2M–$100M (midpoint +26.7%), adjusted EPS $1.26–$1.36 (midpoint $1.31); guidance reflects anticipated ramp and integration timing.
Healthy Balance Sheet and Cash Flow Outlook
Expanded credit facility with $100M term loan to total $350M; invested $147.2M in UnitedHealth acquisition; net debt/adjusted EBITDA 1.7x (well under 3.25x covenant); Q4 operating cash flow $21M, FY YTD $48.3M; forecasted operating cash flow for 2026 $45M–$55M and CapEx ~ $15M.

Pennant Group (PNTG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PNTG Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 11, 2026
2026 (Q1)
0.31 / -
0.27
Feb 25, 2026
2025 (Q4)
0.32 / 0.34
0.2441.67% (+0.10)
Nov 05, 2025
2025 (Q3)
0.29 / 0.30
0.2615.38% (+0.04)
Aug 06, 2025
2025 (Q2)
0.27 / 0.27
0.2412.50% (+0.03)
May 06, 2025
2025 (Q1)
0.24 / 0.27
0.235.00% (+0.07)
Feb 27, 2025
2024 (Q4)
0.24 / 0.24
0.229.09% (+0.02)
Nov 06, 2024
2024 (Q3)
0.23 / 0.26
0.230.00% (+0.06)
Aug 06, 2024
2024 (Q2)
0.21 / 0.24
0.1833.33% (+0.06)
May 06, 2024
2024 (Q1)
0.17 / 0.20
0.1353.85% (+0.07)
Feb 28, 2024
2023 (Q4)
0.22 / 0.22
0.1822.22% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

PNTG Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 25, 2026
$33.09$30.49-7.86%
Nov 05, 2025
$25.17$23.75-5.64%
Aug 06, 2025
$22.26$24.12+8.36%
May 06, 2025
$26.84$27.76+3.43%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Pennant Group Inc (PNTG) report earnings?
Pennant Group Inc (PNTG) is schdueled to report earning on May 11, 2026, After Close (Confirmed).
    What is Pennant Group Inc (PNTG) earnings time?
    Pennant Group Inc (PNTG) earnings time is at May 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PNTG EPS forecast?
          PNTG EPS forecast for the fiscal quarter 2026 (Q1) is 0.31.